Trial NCT05011513

View at ClinicalTrials.gov 
Org. Study IDs: C4671002
Secondary IDs: 2021-002857-28 EPIC-SR

Last trial update was posted on 2023-08-14

MeSH Interventions

Nirmatrelvir Ritonavir

MeSH Conditions

COVID-19

Other Conditions


Stopping Reasons

Enrollment ceased due to a very low rate of hospitalization or death observed in the standard-risk patient population

Limitations And Caveats

In participant flow, there was discontinuations due to AE, which was captured under "Death" as reason for discontinuation. Adverse event was COVID-19 pneumonia and the participant died due to that event and discontinued study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID